Yet another provisional patent application has been filed by PYC.
This one is Improved compositions and methods for treatment of monogenic neurodevelopmental disorders 6.
I’m thinking it unlikely that the six provisional patent applications (all filed since 29/11/23) relate only to the current Phelan McDermid syndrome asset.
Phelan McDermid might just be the first of multiple monogenic neurodevelopmental disorders to be targeted.
https://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2024901708
Yet another provisional patent application has been filed by...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.040(3.45%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.18 | $97.44K | 81.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 19651 | 3 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |